197 related articles for article (PubMed ID: 24192237)
1. Urokinase receptor mediates osteogenic differentiation of mesenchymal stem cells and vascular calcification via the complement C5a receptor.
Kalbasi Anaraki P; Patecki M; Larmann J; Tkachuk S; Jurk K; Haller H; Theilmeier G; Dumler I
Stem Cells Dev; 2014 Feb; 23(4):352-62. PubMed ID: 24192237
[TBL] [Abstract][Full Text] [Related]
2. Urokinase receptor mediates osteoclastogenesis via M-CSF release from osteoblasts and the c-Fms/PI3K/Akt/NF-κB pathway in osteoclasts.
Kalbasi Anaraki P; Patecki M; Tkachuk S; Kiyan Y; Haller H; Dumler I
J Bone Miner Res; 2015 Feb; 30(2):379-88. PubMed ID: 25196912
[TBL] [Abstract][Full Text] [Related]
3. The anaphylatoxin receptor C5aR is present during fracture healing in rats and mediates osteoblast migration in vitro.
Ignatius A; Ehrnthaller C; Brenner RE; Kreja L; Schoengraf P; Lisson P; Blakytny R; Recknagel S; Claes L; Gebhard F; Lambris JD; Huber-Lang M
J Trauma; 2011 Oct; 71(4):952-60. PubMed ID: 21460748
[TBL] [Abstract][Full Text] [Related]
4. Urokinase-induced activation of the gp130/Tyk2/Stat3 pathway mediates a pro-inflammatory effect in human mesangial cells via expression of the anaphylatoxin C5a receptor.
Shushakova N; Tkachuk N; Dangers M; Tkachuk S; Park JK; Hashimoto K; Haller H; Dumler I
J Cell Sci; 2005 Jun; 118(Pt 12):2743-53. PubMed ID: 15944400
[TBL] [Abstract][Full Text] [Related]
5. Silencing of C5a receptor gene with siRNA for protection from Gram-negative bacterial lipopolysaccharide-induced vascular permeability.
Liu ZM; Zhu SM; Qin XJ; Cheng ZD; Liu MY; Zhang HM; Liu DX
Mol Immunol; 2010 Mar; 47(6):1325-33. PubMed ID: 20138669
[TBL] [Abstract][Full Text] [Related]
6. Mesenchymal stem cells recruited by active TGFβ contribute to osteogenic vascular calcification.
Wang W; Li C; Pang L; Shi C; Guo F; Chen A; Cao X; Wan M
Stem Cells Dev; 2014 Jun; 23(12):1392-404. PubMed ID: 24512598
[TBL] [Abstract][Full Text] [Related]
7. Mesenchymal stem cells alleviate acute kidney injury by down-regulating C5a/C5aR pathway activation.
Tang M; Zhang K; Li Y; He QH; Li GQ; Zheng QY; Zhang KQ
Int Urol Nephrol; 2018 Aug; 50(8):1545-1553. PubMed ID: 29594894
[TBL] [Abstract][Full Text] [Related]
8. The urokinase/urokinase receptor system mediates the IgG immune complex-induced inflammation in lung.
Shushakova N; Eden G; Dangers M; Menne J; Gueler F; Luft FC; Haller H; Dumler I
J Immunol; 2005 Sep; 175(6):4060-8. PubMed ID: 16148155
[TBL] [Abstract][Full Text] [Related]
9. C5a/C5aR pathway accelerates renal ischemia-reperfusion injury by downregulating PGRN expression.
Zhang K; Li GQ; He QH; Li Y; Tang M; Zheng QY; Xu GL; Zhang KQ
Int Immunopharmacol; 2017 Dec; 53():17-23. PubMed ID: 29031143
[TBL] [Abstract][Full Text] [Related]
10. Dendritic cell function in allostimulation is modulated by C5aR signaling.
Peng Q; Li K; Wang N; Li Q; Asgari E; Lu B; Woodruff TM; Sacks SH; Zhou W
J Immunol; 2009 Nov; 183(10):6058-68. PubMed ID: 19864610
[TBL] [Abstract][Full Text] [Related]
11. Urokinase receptor mediates mobilization, migration, and differentiation of mesenchymal stem cells.
Vallabhaneni KC; Tkachuk S; Kiyan Y; Shushakova N; Haller H; Dumler I; Eden G
Cardiovasc Res; 2011 Apr; 90(1):113-21. PubMed ID: 21088115
[TBL] [Abstract][Full Text] [Related]
12. C5aR antagonist inhibits occurrence and progression of complement C5a induced inflammatory response of microglial cells through activating p38MAPK and ERK1/2 signaling pathway.
Liu Y; Xu SQ; Long WJ; Zhang XY; Lu HL
Eur Rev Med Pharmacol Sci; 2018 Nov; 22(22):7994-8003. PubMed ID: 30536348
[TBL] [Abstract][Full Text] [Related]
13. Decoy nanoparticles bearing native C5a receptors as a new approach to inhibit complement-mediated neutrophil activation.
Li Y; Lin F
Acta Biomater; 2019 Nov; 99():330-338. PubMed ID: 31446047
[TBL] [Abstract][Full Text] [Related]
14. Prostaglandin E
Lian S; Xia Y; Ung TT; Khoi PN; Yoon HJ; Lee SG; Kim KK; Jung YD
Mol Carcinog; 2017 Feb; 56(2):664-680. PubMed ID: 27377703
[TBL] [Abstract][Full Text] [Related]
15. Hepatic Overexpression of Soluble Urokinase Receptor (uPAR) Suppresses Diet-Induced Atherosclerosis in Low-Density Lipoprotein Receptor-Deficient (LDLR-/-) Mice.
Larmann J; Jurk K; Janssen H; Müller M; Herzog C; Lorenz A; Schmitz M; Nofer JR; Theilmeier G
PLoS One; 2015; 10(8):e0131854. PubMed ID: 26313756
[TBL] [Abstract][Full Text] [Related]
16. Urokinase-receptor-mediated phenotypic changes in vascular smooth muscle cells require the involvement of membrane rafts.
Kiyan J; Smith G; Haller H; Dumler I
Biochem J; 2009 Oct; 423(3):343-51. PubMed ID: 19691446
[TBL] [Abstract][Full Text] [Related]
17. NFκB (Nuclear Factor κ-Light-Chain Enhancer of Activated B Cells) Activity Regulates Cell-Type-Specific and Context-Specific Susceptibility to Calcification in the Aortic Valve.
Gee T; Farrar E; Wang Y; Wu B; Hsu K; Zhou B; Butcher J
Arterioscler Thromb Vasc Biol; 2020 Mar; 40(3):638-655. PubMed ID: 31893948
[TBL] [Abstract][Full Text] [Related]
18. C5a receptor enhances hepatocellular carcinoma cell invasiveness via activating ERK1/2-mediated epithelial-mesenchymal transition.
Hu WH; Hu Z; Shen X; Dong LY; Zhou WZ; Yu XX
Exp Mol Pathol; 2016 Feb; 100(1):101-8. PubMed ID: 26475622
[TBL] [Abstract][Full Text] [Related]
19. TLR4 Response to LPS Is Reinforced by Urokinase Receptor.
Kiyan Y; Tkachuk S; Rong S; Gorrasi A; Ragno P; Dumler I; Haller H; Shushakova N
Front Immunol; 2020; 11():573550. PubMed ID: 33362762
[TBL] [Abstract][Full Text] [Related]
20. Urokinase receptor associates with myocardin to control vascular smooth muscle cells phenotype in vascular disease.
Kiyan Y; Limbourg A; Kiyan R; Tkachuk S; Limbourg FP; Ovsianikov A; Chichkov BN; Haller H; Dumler I
Arterioscler Thromb Vasc Biol; 2012 Jan; 32(1):110-22. PubMed ID: 22075245
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
